source
- J&J reports 40% Q2 sales jump for Spravato as psychedelic rivals loomJohnson & Johnson said its depression nasal spray Spravato generated $584 million in worldwide revenue in the second quarter, a 40% increase from a year earlier. The company highlighted the drug as…
- Sanofi sues Pfizer and Moderna over alleged infringement of mRNA delivery patentsSanofi has filed a lawsuit against Pfizer and Moderna, accusing the two companies of violating its patents covering lipid nanoparticle technology used to deliver mRNA in vaccines. The French drugm…